Publications

Quick Research

Filters Clear All

Any Time

2026
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Country

Argentina
Australia
Austria
Bangladesh
Barbados
Belarus
Belgium
Brazil
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Chile
China
Chinese Taiwan
Croatia
Cyprus
Czech
Czechia
Denmark
Egypt
Estonia
Ethiopia
Finland
France
Gabon
Germany
Ghana
Greece
Guyana
Hungary
India
Indonesia
Iran
Ireland
Israel
Italy
Japan
Kazakhstan
Kenya
Korea
Kuwait
Luxembourg
Madagascar
Malaysia
Mexico
Mongolia
Morocco
Mozambique
Myanmar
Nepal
Netherlands
New Zealand
Niger
Nigeria
Norway
Pakistan
Philippines
Poland
Portugal
Romania
Russia
Russian Federation
Saudi Arabia
Singapore
Slovenia
Somalia
South Africa
South Korea
Spain
Sri Lanka
Sudan
Sweden
Switzerland
Syria
Thailand
Tunisia
Turkey
UAE
UK
USA
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Vietnam

Procell has assisted our customers in publishing 29,572 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.

Filter

2023

O-carboxymethyl chitosan-g-cholesterol derivative nanomicelles functionalized with folic acid for targeted cannabidiol delivery to ovarian cancer cells (2025-11-03)

Journal: JOURNAL OF NANOPARTICLE RESEARCH (2025) IF: 2.6

DOI: 10.1007/s11051-025-06489-7

Products Cited: RPMI-1640 Medium
POGZ targeted by LINC01355/miR-27b-3p retards thyroid cancer progression via interplaying with MAD2L2 (2025-03-08)

Journal: 3 Biotech (2025) IF: 2.6

DOI: 10.1007/s13205-025-04231-7

Products Cited: CAL-62 Cells Line
Identification of AKTIP as a biomarker for fibrolamellar carcinoma using WGCNA and machine learning (2025-05-21)

Journal: 3 Biotech (2025) IF: 2.6

DOI: 10.1007/s13205-025-04323-4

Products Cited: THLE-2 Cells Line
The Regulation of ZAR1 on Apoptosis and Mitophagy in Ovarian Granular Cells and Primary Ovarian Insufficiency (POI) Mice (2025-04-11)

Journal: Reproductive Sciences (2025) IF: 2.6

DOI: 10.1007/s43032-025-01857-z

Products Cited: KGN Cells Line
Formulation and optimization of glycyrrhetinic acid-modified pH-sensitive curcumin liposomes for anti-hepatocellular carcinoma (2025-02-13)

Journal: PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2025) IF: 2.6

DOI: 10.1080/10837450.2025.2465549

Products Cited: DMEM (High glucose) Medium
Exosome-Delivered Hsa_Circ_0000116 Facilitates Osteosarcoma Cell Malignancy via PI3K/Akt/mTOR and p38/MAPK Pathways (2025-01-08)

Journal: DNA AND CELL BIOLOGY (2025) IF: 2.6

DOI: 10.1089/dna.2024.0245

Products Cited: MEM Medium, Fetal Bovine Serum, MG-63 Cells Line, HOS Cells Line
LncRNA HOXC-AS1 Promotes Tumor Progression via miR-876-3p/NR3C1 in Hepatocellular Carcinoma (2025-12-09)

Journal: APMIS (2025) IF: 2.6

DOI: 10.1111/apm.70108

Products Cited: THLE-2 Cells Line, Hep 3B2.1-7 Cells Line, MHCC97-H Cells Line
High Glucose-Induced Senescent Fibroblasts-Derived Exosomal miR-497 Inhibits Wound Healing by Regulating Endothelial Cellular Autophagy via ATG13 (2025-01-10)

Journal: Analytical Cellular Pathology (2025) IF: 2.6

DOI: 10.1155/ancp/8890200

Products Cited: NCTC clone 929 [L cell, L-929] Cells Line, Human Umbilical Vein Endothelial Cells
COL22A1 Activates the PI3K/AKT Signaling Pathway to Sustain the Malignancy of Glioblastoma (2025-05-21)

Journal: International Journal of Genomics (2025) IF: 2.6

DOI: 10.1155/ijog/6587097

Products Cited: A172 Cells Line, Fetal Bovine Serum, Penicillin-Streptomycin Solution, 100 ×, MEM Medium, DMEM (High glucose) Medium, U-87 MG Cells Line, LN229 [LN-229; LNT-229] Cells Line
IGF2BP3 is upregulated in endometrial cancer and tightly regulates the growth of drug-resistant endometrial cancer cells via HMGA1 (2025-01-29)

Journal: SCIENCE PROGRESS (2025) IF: 2.6

DOI: 10.1177/00368504251315008

Products Cited: Ishikawa Cells Line, AN3 CA Cells Line